Does EVOLOCUMAB Cause Gastrointestinal disorder? 273 Reports in FDA Database

Q: Does EVOLOCUMAB cause Gastrointestinal disorder?

273 reports of Gastrointestinal disorder have been filed with the FDA for EVOLOCUMAB, representing 0.2% of all EVOLOCUMAB adverse event reports.

Q: How dangerous is Gastrointestinal disorder from EVOLOCUMAB?

Of 273 reports, 5 (1.8%) resulted in death and 39 required hospitalization.

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 273 reports of Gastrointestinal disorder have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.

273

Reports of Gastrointestinal disorder with EVOLOCUMAB

0.2%

of all EVOLOCUMAB reports

Deaths

Hospitalizations

How Dangerous Is Gastrointestinal disorder From EVOLOCUMAB?

Of the 273 reports, 5 (1.8%) resulted in death, 39 (14.3%) required hospitalization, and 2 (0.7%) were considered life-threatening.

Is Gastrointestinal disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 273 reports have been filed with the FAERS database.

What Other Side Effects Does EVOLOCUMAB Cause?

Device difficult to use (31,807) Drug dose omission by device (23,957) Wrong technique in product usage process (21,664) Accidental exposure to product (16,160) Injection site pain (9,988) Product storage error (6,606)